The CEO of Portage Biotech (PRTG), Ian Walters, says that the clinical stage immuno-oncology company is developing checkpoint immunotherapies to help cancer patients achieve longer treatment responses and a better quality of life.
The Watch List
03 Mar 2021
SHARE
The Watch List
09 Dec 2021
The Watch List
04 Jan 2022
Market On Close
22 Dec 2021
Trading 360
10 Jan 2022
The Watch List
22 Feb 2022
The Watch List
08 Feb 2022